Haemonetics Corp. HAE

NYS: HAE | ISIN: US4050241003 2/10/2026

104,68 USD (+0,30%)

(+0,30%) 2/10/2026

Grafiek Haemonetics Corp.

Grafiek Haemonetics Corp.

1 dag1d 0,30%
1 week1w -1,05%
1 maand1m 1,79%
3 maanden3m 39,54%
6 maanden6m 79,06%
1 jaar1j 111,26%
5 jaar5j 52,42%

Haemonetics Corp. in het nieuws

Toon enkel gratis nieuws

30 september 2026 · Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2027 Results: November 5, 2026 · Persbericht

6 augustus 2026 · Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website · Persbericht

3 augustus 2026 · New Study Offers Additional Evidence for the VASCADE MVP® XL System's Effectiveness in Electrophysiology Procedures with Large Bore Sheaths · Persbericht

28 juli 2026 · Martin Madaus Elected to Haemonetics Board of Directors · Persbericht

8 juli 2026 · Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2027 Results: August 6, 2026 · Persbericht

5 juni 2026 · Haemonetics Updates Financial Reporting Segments · Persbericht

2 juni 2026 · Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference · Persbericht

7 mei 2026 · Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website · Persbericht

5 mei 2026 · Haemonetics to Present at Bank of America 2026 Healthcare Conference · Persbericht

24 april 2026 · New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures · Persbericht

Profiel Haemonetics Corp.

Gezondheidstechnologie

Medische Specialiteiten

Productie van medische instrumenten

Website: www.haemonetics.com

Hoofdzetel: Boston, Massachusetts Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe